INTERNATIONAL PATENT: PROXYGEN GMBH FILES APPLICATION FOR "1H-PYRAZOL-4-YL-ACETAMIDE DERIVATIVES FOR USE IN CULLIN-RING UBIQUITIN LIGASE (CRL) CONJUGATES COMPRISING THE COMPOUND-LINKER AND A TARGETING MOIETY FOR THE TREATMENT OF E.G. CANCER"

GENEVA, Jan. 26 -- PROXYGEN GMBH (SiemensstraBe 891210 Vienna) filed a patent application (PCT/EP2025/070729) for "1H-PYRAZOL-4-YL-ACETAMIDE DERIVATIVES FOR USE IN CULLIN-RING UBIQUITIN LIGASE (CRL) CONJUGATES COMPRISING THE COMPOUND-LINKER AND A TARGETING MOIETY FOR THE TREATMENT OF E.G. CANCER" on Jul 18, 2025. With publication no. WO/2026/017889, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): THOMSON, Douglas (c/o Proxygen GmbHSiemensstraBe 891210 Vienna), FORSTER, Francis (c/o Proxygen GmbHSiemensstraBe 891210 Vienna...